@WHO: 💊 WHO strongly recommends the use of nirmatrelvir/ritonavir (sold as Paxlovid) in people with mild/moderate #COVID19, who are at high risk of hospitalization (such as unvaccinated, older, or immunosuppressed people). https://t.co/GGbKCzXdDE

@WHO: 💊 WHO strongly recommends the use of nirmatrelvir/ritonavir (sold as Paxlovid) in people with mild/moderate #COVID19, who are at high risk of hospitalization (such as unvaccinated, older, or immunosuppressed people). https://t.co/GGbKCzXdDE

http://twitter.com/WHO
via IFTTT

Comments